SLC6A3 and Parkinson disease: A case report of comorbid PD and schizophrenia presented two patients with significantly decreased dopamine transporter density in the striatum on F-18-N-(3-fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl) nortropane positron emission tomography, which indicated genuine PD rather than drug-induced parkinsonism [13].